blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2162141

EP2162141 - COMPOSITION FOR TREATING ISCHEMIC LIMB DISEASE COMPRISING STEM CELLS DERIVED FROM ADIPOSE TISSUE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  18.07.2014
Database last updated on 19.07.2024
Most recent event   Tooltip15.07.2016Lapse of the patent in a contracting state
New state(s): TR		published on 17.08.2016  [2016/33]
Applicant(s)For all designated states
RNL Bio Co., Ltd.
1596-7 Bongcheon-dong Gwanak-gu
Seoul 151-050 / KR
[2010/11]
Inventor(s)01 / RA, Jeong Chan
626-701 Cheongsolmaeul
SK Hanhwa APT., 918, Jeongja-dong
Jangan-gu
Suwon-si
Gyeonggi-do 440-300 / KR
02 / HAN, Hae Jung
5201-201 Chodang Maeul Hyunjin
Everville Apt.
13-2 Jung-dong
Giheung-gu
Yongin-si Gyeonggi-do 446-718 / KR
03 / LEE, Hang Young
526-1803
Baekseol Maeul Jinlo Apt.
Jeongja-dong
Jangan-gu
Suwon-si Gyeonggi-do 440-719 / KR
04 / KIM, Hyo Eun
105-601 Lotte Apt.
Guro 5-dong
Guro-gu
Seoul 152-770 / KR
 [2013/37]
Former [2010/11]01 / RA, Jeong Chan
626-701 Cheongsolmaeul SK Hanhwa APT., 918, Jeongja-dong Jangan-gu Suwon-si
Gyeonggi-do 440-300 / KR
02 / HAN, Hae Jung
5201-201 Chodang Maeul Hyunjin Everville Apt. 13-2 Jung-dong Giheung-gu
Yongin-si Gyeonggi-do 446-718 / KR
03 / LEE, Hang Young
526-1803 Baekseol Maeul Jinlo Apt. Jeongja-dong Jangan-gu
Suwon-si Gyeonggi-do 440-719 / KR
04 / KIM, Hyo Eun
105-601 Lotte Apt. Guro 5-dong Guro-gu
Seoul 152-770 / KR
Representative(s)Hiebl, Inge Elisabeth, et al
Kraus & Weisert
Patentanwälte PartGmbB
Thomas-Wimmer-Ring 15
80539 München / DE
[N/P]
Former [2010/11]Hiebl, Inge Elisabeth, et al
Kraus & Weisert Patent- und Rechtsanwälte Thomas-Wimmer-Ring 15
80539 München / DE
Application number, filing date08753410.309.05.2008
[2010/11]
WO2008KR02614
Priority number, dateKR2007005062425.05.2007         Original published format: KR 20070050624
[2010/11]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008147057
Date:04.12.2008
Language:EN
[2008/49]
Type: A1 Application with search report 
No.:EP2162141
Date:17.03.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 04.12.2008 takes the place of the publication of the European patent application.
[2010/11]
Type: B1 Patent specification 
No.:EP2162141
Date:11.09.2013
Language:EN
[2013/37]
Search report(s)International search report - published on:KR04.12.2008
(Supplementary) European search report - dispatched on:EP30.12.2010
ClassificationIPC:A61K35/28, A01N63/00, A61K45/06, A61P25/02, A61K9/10, A61K38/38, A61K9/08, A61K31/10, A61K31/198, A61K47/02, A61K47/18, A61K47/20, A61K47/26, A61K47/42, A61K9/00
[2013/17]
CPC:
A61K31/10 (EP,US); A61K31/198 (EP,US); A61K35/28 (EP,KR,US);
A61K38/38 (EP,US); A61K45/06 (EP,US); A61K47/02 (EP,US);
A61K47/183 (EP,US); A61K47/20 (EP,US); A61K47/26 (EP,KR,US);
A61K47/42 (EP,KR,US); A61K9/0019 (EP,US); A61K9/08 (EP,US);
A61K9/10 (EP,US); A61P17/02 (EP); A61P25/02 (EP);
A61P7/00 (EP); A61P7/02 (EP); A61P9/10 (EP);
A61P9/14 (EP) (-)
C-Set:
A61K31/10, A61K2300/00 (EP,US);
A61K31/198, A61K2300/00 (US,EP);
A61K35/28, A61K2300/00 (US,EP);
A61K38/38, A61K2300/00 (US,EP)
Former IPC [2010/11]A61K35/34, A01N63/00, C12N5/06, A61K45/00, A61P25/02
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/11]
TitleGerman:ZUSAMMENSETZUNG ZUR BEHANDLUNG VON ISCHÄMISCHER ERKRANKUNG DER EXTREMITÄTEN MIT STAMMZELLEN AUS FETTGEWEBE[2010/11]
English:COMPOSITION FOR TREATING ISCHEMIC LIMB DISEASE COMPRISING STEM CELLS DERIVED FROM ADIPOSE TISSUE[2010/11]
French:COMPOSITION POUR LE TRAITEMENT D'UNE MALADIE ISCHÉMIQUE DES MEMBRES COMPRENANT DES CELLULES SOUCHES DÉRIVÉES DE TISSU ADIPEUX[2010/11]
Entry into regional phase24.11.2009National basic fee paid 
24.11.2009Search fee paid 
24.11.2009Designation fee(s) paid 
24.11.2009Examination fee paid 
Examination procedure24.11.2009Examination requested  [2010/11]
21.07.2011Amendment by applicant (claims and/or description)
13.03.2012Despatch of a communication from the examining division (Time limit: M04)
12.07.2012Reply to a communication from the examining division
15.05.2013Communication of intention to grant the patent
31.07.2013Fee for grant paid
31.07.2013Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  13.03.2012
Opposition(s)12.06.2014No opposition filed within time limit [2014/34]
Fees paidRenewal fee
17.03.2010Renewal fee patent year 03
04.05.2011Renewal fee patent year 04
08.03.2012Renewal fee patent year 05
29.05.2013Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU09.05.2008
AT11.09.2013
BE11.09.2013
BG11.09.2013
CY11.09.2013
CZ11.09.2013
DK11.09.2013
EE11.09.2013
FI11.09.2013
HR11.09.2013
LT11.09.2013
LV11.09.2013
MC11.09.2013
MT11.09.2013
NL11.09.2013
PL11.09.2013
RO11.09.2013
SE11.09.2013
SI11.09.2013
SK11.09.2013
TR11.09.2013
NO11.12.2013
GR12.12.2013
IS11.01.2014
PT13.01.2014
IE09.05.2014
LU09.05.2014
CH31.05.2014
LI31.05.2014
[2016/33]
Former [2016/32]HU09.05.2008
AT11.09.2013
BE11.09.2013
BG11.09.2013
CY11.09.2013
CZ11.09.2013
DK11.09.2013
EE11.09.2013
FI11.09.2013
HR11.09.2013
LT11.09.2013
LV11.09.2013
MC11.09.2013
MT11.09.2013
NL11.09.2013
PL11.09.2013
RO11.09.2013
SE11.09.2013
SI11.09.2013
SK11.09.2013
NO11.12.2013
GR12.12.2013
IS11.01.2014
PT13.01.2014
IE09.05.2014
LU09.05.2014
CH31.05.2014
LI31.05.2014
Former [2016/25]AT11.09.2013
BE11.09.2013
BG11.09.2013
CY11.09.2013
CZ11.09.2013
DK11.09.2013
EE11.09.2013
FI11.09.2013
HR11.09.2013
LT11.09.2013
LV11.09.2013
MC11.09.2013
MT11.09.2013
NL11.09.2013
PL11.09.2013
RO11.09.2013
SE11.09.2013
SI11.09.2013
SK11.09.2013
NO11.12.2013
GR12.12.2013
IS11.01.2014
PT13.01.2014
IE09.05.2014
LU09.05.2014
CH31.05.2014
LI31.05.2014
Former [2016/16]AT11.09.2013
BE11.09.2013
CY11.09.2013
CZ11.09.2013
DK11.09.2013
EE11.09.2013
FI11.09.2013
HR11.09.2013
LT11.09.2013
LV11.09.2013
MC11.09.2013
MT11.09.2013
NL11.09.2013
PL11.09.2013
RO11.09.2013
SE11.09.2013
SI11.09.2013
SK11.09.2013
NO11.12.2013
GR12.12.2013
IS11.01.2014
PT13.01.2014
IE09.05.2014
LU09.05.2014
CH31.05.2014
LI31.05.2014
Former [2015/21]AT11.09.2013
BE11.09.2013
CY11.09.2013
CZ11.09.2013
DK11.09.2013
EE11.09.2013
FI11.09.2013
HR11.09.2013
LT11.09.2013
LV11.09.2013
MC11.09.2013
NL11.09.2013
PL11.09.2013
RO11.09.2013
SE11.09.2013
SI11.09.2013
SK11.09.2013
NO11.12.2013
GR12.12.2013
IS11.01.2014
PT13.01.2014
IE09.05.2014
LU09.05.2014
CH31.05.2014
LI31.05.2014
Former [2015/09]AT11.09.2013
BE11.09.2013
CY11.09.2013
CZ11.09.2013
DK11.09.2013
EE11.09.2013
FI11.09.2013
HR11.09.2013
LT11.09.2013
LV11.09.2013
MC11.09.2013
NL11.09.2013
PL11.09.2013
RO11.09.2013
SE11.09.2013
SI11.09.2013
SK11.09.2013
NO11.12.2013
GR12.12.2013
IS11.01.2014
PT13.01.2014
LU09.05.2014
CH31.05.2014
LI31.05.2014
Former [2015/08]AT11.09.2013
BE11.09.2013
CY11.09.2013
CZ11.09.2013
DK11.09.2013
EE11.09.2013
FI11.09.2013
HR11.09.2013
LT11.09.2013
LV11.09.2013
NL11.09.2013
PL11.09.2013
RO11.09.2013
SE11.09.2013
SI11.09.2013
SK11.09.2013
NO11.12.2013
GR12.12.2013
IS11.01.2014
PT13.01.2014
LU09.05.2014
CH31.05.2014
LI31.05.2014
Former [2015/04]AT11.09.2013
BE11.09.2013
CY11.09.2013
CZ11.09.2013
DK11.09.2013
EE11.09.2013
FI11.09.2013
HR11.09.2013
LT11.09.2013
LV11.09.2013
NL11.09.2013
PL11.09.2013
RO11.09.2013
SE11.09.2013
SI11.09.2013
SK11.09.2013
NO11.12.2013
GR12.12.2013
IS11.01.2014
PT13.01.2014
LU09.05.2014
Former [2014/41]AT11.09.2013
BE11.09.2013
CY11.09.2013
CZ11.09.2013
DK11.09.2013
EE11.09.2013
FI11.09.2013
HR11.09.2013
LT11.09.2013
LV11.09.2013
NL11.09.2013
PL11.09.2013
RO11.09.2013
SE11.09.2013
SI11.09.2013
SK11.09.2013
NO11.12.2013
GR12.12.2013
IS11.01.2014
PT13.01.2014
Former [2014/28]AT11.09.2013
BE11.09.2013
CY11.09.2013
CZ11.09.2013
EE11.09.2013
FI11.09.2013
HR11.09.2013
LT11.09.2013
LV11.09.2013
NL11.09.2013
PL11.09.2013
RO11.09.2013
SE11.09.2013
SI11.09.2013
SK11.09.2013
NO11.12.2013
GR12.12.2013
IS11.01.2014
PT13.01.2014
Former [2014/24]AT11.09.2013
BE11.09.2013
CY11.09.2013
CZ11.09.2013
EE11.09.2013
FI11.09.2013
HR11.09.2013
LT11.09.2013
LV11.09.2013
NL11.09.2013
PL11.09.2013
RO11.09.2013
SE11.09.2013
SI11.09.2013
SK11.09.2013
NO11.12.2013
GR12.12.2013
IS11.01.2014
Former [2014/23]BE11.09.2013
CY11.09.2013
CZ11.09.2013
EE11.09.2013
FI11.09.2013
HR11.09.2013
LT11.09.2013
LV11.09.2013
NL11.09.2013
RO11.09.2013
SE11.09.2013
SI11.09.2013
SK11.09.2013
NO11.12.2013
GR12.12.2013
IS11.01.2014
Former [2014/22]BE11.09.2013
CY11.09.2013
FI11.09.2013
HR11.09.2013
LT11.09.2013
LV11.09.2013
NL11.09.2013
RO11.09.2013
SE11.09.2013
SI11.09.2013
NO11.12.2013
GR12.12.2013
Former [2014/18]BE11.09.2013
CY11.09.2013
FI11.09.2013
HR11.09.2013
LT11.09.2013
LV11.09.2013
SE11.09.2013
SI11.09.2013
NO11.12.2013
GR12.12.2013
Former [2014/12]CY21.08.2013
FI11.09.2013
HR11.09.2013
LT11.09.2013
LV11.09.2013
SE11.09.2013
SI11.09.2013
NO11.12.2013
GR12.12.2013
Former [2014/10]CY21.08.2013
HR11.09.2013
LT11.09.2013
SE11.09.2013
NO11.12.2013
Former [2014/09]HR11.09.2013
LT11.09.2013
SE11.09.2013
NO11.12.2013
Former [2014/08]LT11.09.2013
NO11.12.2013
Former [2014/07]NO11.12.2013
Documents cited:Search[XY]WO2006134951  (BIOMASTER INC [JP], et al) [X] 1-6 * Description;; example 4; claim - * [Y] 1-6;
 [XY]WO2006136244  (CELLERIX SL [ES], et al) [X] 1-3,5 * paragraphs [0052] , [0 89]; example 2; claim - * [Y] 1-6;
 [Y]  - THIRUMALA S ET AL, "Transport phenomena during freezing of adipose tissue derived adult stem cells", BIOTECHNOLOGY AND BIOENGINEERING 20051105 JOHN WILEY AND SONS INC. US, (20051105), vol. 92, no. 3, doi:DOI:10.1002/BIT.20615, pages 372 - 383, XP009142402 [Y] 1-6 * abstract *

DOI:   http://dx.doi.org/10.1002/bit.20615
International search[X]WO03059272  (FORD HENRY HEALTH SYSTEM [US], et al);
 [X]WO2005034843  (MACROPORE BIOSURGERY INC [US], et al);
 [X]  - REHMAN J. ET AL., "Angiogenic potential of subcutaneous adipose stromal cells for autologous cell therapy", JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, (20030319), vol. 41, no. 6, SUPPL. A, page 308A, XP009028844

DOI:   http://dx.doi.org/10.1016/S0735-1097(03)82443-9
 [X]  - PLANAT-BENARD V. ET AL., "Plasticity of Human Adipose Lineage Cells Toward Endothelial Cells: Physiological and Therapeutic Perspectives", CIRCULATION, (20040210), vol. 109, no. 5, pages 656 - 663, XP009034616

DOI:   http://dx.doi.org/10.1161/01.CIR.0000114522.38265.61
 [X]  - MIRANVILLE A. ET AL., "Human adipose tissue-derived stem cells improve blood flow in the ischemic mouse hind-limb", CIRCULATION, (20031028), vol. 108, no. 17, SUPPL., page IV-164, XP008048883
 [A]  - STASHOWER M. ET AL., "Stromal progenitor cells present within liposuction and reduction abdominoplasty fat for autologous transfer to aged skin", DERMATOLOGIC SURGERY, (1999), vol. 25, no. 12, pages 945 - 949, XP002233641

DOI:   http://dx.doi.org/10.1046/j.1524-4725.1999.99098.x
 [A]  - RANGAPPA S. ET AL., "Transformation of adult mesenchymal stem cells isolated from the fatty tissue into cardiomyocytes", ANNALS OF THORACIC SURGERY, (200303), vol. 75, no. 3, pages 775 - 779, XP002401034

DOI:   http://dx.doi.org/10.1016/S0003-4975(02)04568-X
by applicantUS6777231
 WO2006134951
 WO2006136244
 WO03059272
 KR20030034177
 KR20050111593
    - BRZOSKA ET AL., BBRC, (2005), vol. 330, page 142
    - CAO ET AL., BBRC, (2005), vol. 332, page 370
    - SAFFORD ET AL., BBRC, (2002), vol. 294, page 371
    - OGAWA ET AL., BBRC, (2004), vol. 319, page 511
    - OGAWA ET AL., BBRC, (2004), vol. 313, page 871
    - BIOMATERIALS, (2004), vol. 25, page 3211
    - FUJIMURA ET AL., BBRC, (2005), vol. 333, page 116
    - INT. IMMUNOL., (1998), vol. 10, no. 3, page 275
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.